

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.64717576 |
| 2 | glycine transport (GO:0015816) | 5.97414702 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.91706723 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.86890059 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.71665642 |
| 6 | sodium ion export (GO:0071436) | 5.50985795 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.43694863 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.43694863 |
| 9 | neuromuscular process controlling posture (GO:0050884) | 5.33688031 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 5.33676802 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.25299451 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 5.18501635 |
| 13 | glutamate secretion (GO:0014047) | 5.14238294 |
| 14 | locomotory exploration behavior (GO:0035641) | 5.10978478 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.09946669 |
| 16 | neurofilament cytoskeleton organization (GO:0060052) | 4.95800718 |
| 17 | * neurotransmitter secretion (GO:0007269) | 4.79576443 |
| 18 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.76453242 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.76184370 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.63017863 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.58518976 |
| 22 | leukocyte aggregation (GO:0070486) | 4.56899596 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 4.53450280 |
| 24 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.50877608 |
| 25 | L-amino acid import (GO:0043092) | 4.46955701 |
| 26 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.44807310 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.38886663 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.35804046 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.33169688 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.33155272 |
| 31 | potassium ion import (GO:0010107) | 4.32761219 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30289131 |
| 33 | proline transport (GO:0015824) | 4.25420752 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14383817 |
| 35 | potassium ion homeostasis (GO:0055075) | 4.12496153 |
| 36 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.11913221 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 4.10906435 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10493300 |
| 39 | * neurotransmitter transport (GO:0006836) | 4.09533285 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.08229221 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.06980156 |
| 42 | positive thymic T cell selection (GO:0045059) | 4.05337879 |
| 43 | cell communication by electrical coupling (GO:0010644) | 4.00298372 |
| 44 | vocalization behavior (GO:0071625) | 3.99110672 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.99080169 |
| 46 | response to interleukin-15 (GO:0070672) | 3.97668916 |
| 47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.96605706 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.96535628 |
| 49 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.94754518 |
| 50 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.87737832 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86429276 |
| 52 | membrane depolarization during action potential (GO:0086010) | 3.84096347 |
| 53 | negative T cell selection (GO:0043383) | 3.83320447 |
| 54 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.82872797 |
| 55 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.73744974 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.73175632 |
| 57 | positive regulation of Rap GTPase activity (GO:0032854) | 3.72175373 |
| 58 | activation of protein kinase A activity (GO:0034199) | 3.70133152 |
| 59 | exploration behavior (GO:0035640) | 3.68535225 |
| 60 | cellular response to interleukin-15 (GO:0071350) | 3.68088617 |
| 61 | axon cargo transport (GO:0008088) | 3.67240820 |
| 62 | * regulation of neurotransmitter levels (GO:0001505) | 3.65527225 |
| 63 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.65521078 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.62669753 |
| 65 | thymic T cell selection (GO:0045061) | 3.60029764 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.56282688 |
| 67 | positive T cell selection (GO:0043368) | 3.55313443 |
| 68 | synaptic vesicle endocytosis (GO:0048488) | 3.53952931 |
| 69 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.53859323 |
| 70 | protein localization to synapse (GO:0035418) | 3.51880186 |
| 71 | cellular sodium ion homeostasis (GO:0006883) | 3.51272517 |
| 72 | adult walking behavior (GO:0007628) | 3.51171693 |
| 73 | neuron-neuron synaptic transmission (GO:0007270) | 3.49910394 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.49008728 |
| 75 | synaptic transmission, glutamatergic (GO:0035249) | 3.48365086 |
| 76 | neuromuscular process controlling balance (GO:0050885) | 3.43068302 |
| 77 | signal complex assembly (GO:0007172) | 3.42792304 |
| 78 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.40821868 |
| 79 | amino acid import (GO:0043090) | 3.36898590 |
| 80 | T cell selection (GO:0045058) | 3.35784433 |
| 81 | vesicle transport along microtubule (GO:0047496) | 3.35461180 |
| 82 | positive regulation of potassium ion transport (GO:0043268) | 3.34704975 |
| 83 | T cell migration (GO:0072678) | 3.34080962 |
| 84 | regulation of neurotransmitter secretion (GO:0046928) | 3.33985973 |
| 85 | glutamate receptor signaling pathway (GO:0007215) | 3.33805454 |
| 86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31696196 |
| 87 | long-term memory (GO:0007616) | 3.31330868 |
| 88 | layer formation in cerebral cortex (GO:0021819) | 3.30098181 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 3.28905249 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 3.27969519 |
| 91 | regulation of Rap GTPase activity (GO:0032317) | 3.26201543 |
| 92 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25000053 |
| 93 | transmission of nerve impulse (GO:0019226) | 3.20513318 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 3.20379668 |
| 95 | regulation of ARF protein signal transduction (GO:0032012) | 3.19667162 |
| 96 | regulation of neurotransmitter transport (GO:0051588) | 3.18091752 |
| 97 | neuromuscular synaptic transmission (GO:0007274) | 3.16125783 |
| 98 | activation of MAPKKK activity (GO:0000185) | 3.14634660 |
| 99 | neuromuscular process (GO:0050905) | 3.13751436 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 3.12427314 |
| 101 | modulation by symbiont of host defense response (GO:0052031) | 3.12427314 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.12427314 |
| 103 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.12427314 |
| 104 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.12427314 |
| 105 | modulation by symbiont of host immune response (GO:0052553) | 3.12427314 |
| 106 | detection of bacterium (GO:0016045) | 3.10774420 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.10428276 |
| 108 | membrane repolarization (GO:0086009) | 3.08712790 |
| 109 | germinal center formation (GO:0002467) | 3.08246633 |
| 110 | regulation of B cell differentiation (GO:0045577) | 3.08244246 |
| 111 | detection of other organism (GO:0098543) | 3.07562189 |
| 112 | neuron cell-cell adhesion (GO:0007158) | 3.07477245 |
| 113 | cell differentiation in hindbrain (GO:0021533) | 3.04282249 |
| 114 | cell migration in hindbrain (GO:0021535) | 3.00302691 |
| 115 | membrane hyperpolarization (GO:0060081) | 3.00261826 |
| 116 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98164706 |
| 117 | response to auditory stimulus (GO:0010996) | 2.98129822 |
| 118 | organelle transport along microtubule (GO:0072384) | 2.96260050 |
| 119 | cell communication involved in cardiac conduction (GO:0086065) | 2.95705288 |
| 120 | neuronal ion channel clustering (GO:0045161) | 2.95651203 |
| 121 | negative regulation of microtubule polymerization (GO:0031115) | 2.95173985 |
| 122 | regulation of synaptic plasticity (GO:0048167) | 2.94968951 |
| 123 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.94684033 |
| 124 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.94549495 |
| 125 | membrane depolarization (GO:0051899) | 2.94046254 |
| 126 | regulation of vesicle fusion (GO:0031338) | 2.93221335 |
| 127 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.93120643 |
| 128 | * synaptic transmission (GO:0007268) | 2.92325119 |
| 129 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.91644139 |
| 130 | cerebellar granule cell differentiation (GO:0021707) | 2.88564170 |
| 131 | negative regulation of type 2 immune response (GO:0002829) | 2.88434569 |
| 132 | interferon-gamma production (GO:0032609) | 2.87214804 |
| 133 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.86326136 |
| 134 | mating behavior (GO:0007617) | 2.85720494 |
| 135 | mast cell activation (GO:0045576) | 2.85600655 |
| 136 | regulation of postsynaptic membrane potential (GO:0060078) | 2.84948578 |
| 137 | neurotransmitter uptake (GO:0001504) | 2.84780283 |
| 138 | calcium ion-dependent exocytosis (GO:0017156) | 2.83925900 |
| 139 | positive regulation of granulocyte differentiation (GO:0030854) | 2.82984667 |
| 140 | response to pheromone (GO:0019236) | 2.82768436 |
| 141 | prepulse inhibition (GO:0060134) | 2.82760989 |
| 142 | positive regulation of membrane potential (GO:0045838) | 2.82189689 |
| 143 | activated T cell proliferation (GO:0050798) | 2.81373105 |
| 144 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80076536 |
| 145 | Peyers patch development (GO:0048541) | 2.79626122 |
| 146 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.79626122 |
| 147 | positive regulation of type 2 immune response (GO:0002830) | 2.79463517 |
| 148 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79085484 |
| 149 | righting reflex (GO:0060013) | 2.78962248 |
| 150 | long-term synaptic potentiation (GO:0060291) | 2.78915275 |
| 151 | mast cell degranulation (GO:0043303) | 2.77331731 |
| 152 | mast cell activation involved in immune response (GO:0002279) | 2.77331731 |
| 153 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76639530 |
| 154 | cellular extravasation (GO:0045123) | 2.76612535 |
| 155 | dendrite morphogenesis (GO:0048813) | 2.75860922 |
| 156 | positive regulation of synapse maturation (GO:0090129) | 2.75433367 |
| 157 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.75056795 |
| 158 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.74843748 |
| 159 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74688244 |
| 160 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.74553299 |
| 161 | regulation of synaptic transmission (GO:0050804) | 2.73267419 |
| 162 | myeloid cell activation involved in immune response (GO:0002275) | 2.70112053 |
| 163 | natural killer cell differentiation (GO:0001779) | 2.68768844 |
| 164 | regulation of regulated secretory pathway (GO:1903305) | 2.64263679 |
| 165 | regulation of type 2 immune response (GO:0002828) | 2.63833862 |
| 166 | T cell homeostasis (GO:0043029) | 2.62153029 |
| 167 | response to muramyl dipeptide (GO:0032495) | 2.61218193 |
| 168 | positive regulation of T cell cytokine production (GO:0002726) | 2.58075465 |
| 169 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.57682801 |
| 170 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.56757461 |
| 171 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.55990908 |
| 172 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.55196529 |
| 173 | response to type I interferon (GO:0034340) | 2.54321433 |
| 174 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.54038504 |
| 175 | type I interferon signaling pathway (GO:0060337) | 2.53935143 |
| 176 | cellular response to type I interferon (GO:0071357) | 2.53935143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.03097982 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.65764327 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.64908013 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.19148365 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00586419 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92723534 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87962089 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.79559883 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78975689 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.78072005 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77951250 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70893609 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70323761 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70323761 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.62071313 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55021136 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53723675 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52255092 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.51046344 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49943820 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.49243951 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.47476543 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.44662288 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44273209 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.39081107 |
| 26 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39079953 |
| 27 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38858581 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33894086 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29446649 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28055021 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.26580230 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.26149212 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25070928 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21308252 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.16033016 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15159452 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13829199 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.12831327 |
| 39 | * MAF_26560356_Chip-Seq_TH2_Human | 2.11821723 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11629421 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.09716369 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09079854 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05935082 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05127115 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.02548421 |
| 46 | * MYB_26560356_Chip-Seq_TH2_Human | 1.99359205 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96997093 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91707766 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89959411 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.89923448 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88747112 |
| 52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88606577 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84425624 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83351282 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81866648 |
| 56 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76979202 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74494318 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71351745 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69964550 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.69563328 |
| 61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68951493 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68162685 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66369183 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65247964 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64478089 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.57338589 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56824510 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54645042 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52228424 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51675022 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50871101 |
| 72 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.47264900 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46503943 |
| 74 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.44874829 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44601938 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43401864 |
| 77 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42818695 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42520270 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37645904 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.37481430 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35620310 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35586373 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34813417 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33630919 |
| 85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33175761 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32852616 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32096641 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31332931 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29405685 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27271893 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26066012 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25868717 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25765271 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25401230 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25105269 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23809915 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23794537 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 1.23267652 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21914032 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21575432 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20553091 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16936056 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16496655 |
| 104 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15444752 |
| 105 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15060149 |
| 106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14404943 |
| 107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14133562 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13943774 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13212768 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11643849 |
| 111 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.10971077 |
| 112 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08998893 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07352160 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06311939 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05894447 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05624862 |
| 117 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.03750707 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03642606 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03159188 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03035909 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02287385 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02051611 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00918869 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00297271 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00207227 |
| 126 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99853266 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99792533 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99731243 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99684603 |
| 130 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99672347 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99196834 |
| 132 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98545465 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97612716 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97399407 |
| 135 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97192031 |
| 136 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97148179 |
| 137 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96247972 |
| 138 | * FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95635184 |
| 139 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95621115 |
| 140 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95600668 |
| 141 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.95311596 |
| 142 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95304545 |
| 143 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95294563 |
| 144 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95143935 |
| 145 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94450249 |
| 146 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94420878 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93153531 |
| 148 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92961728 |
| 149 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92921176 |
| 150 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92774944 |
| 151 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92730197 |
| 152 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92156903 |
| 153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92029982 |
| 154 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91323666 |
| 155 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89731879 |
| 156 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88645001 |
| 157 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86642307 |
| 158 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85363892 |
| 159 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85269884 |
| 160 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85203546 |
| 161 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85002293 |
| 162 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84938948 |
| 163 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84121186 |
| 164 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82648962 |
| 165 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81393041 |
| 166 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81190860 |
| 167 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80784139 |
| 168 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80525088 |
| 169 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80100319 |
| 170 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.79773543 |
| 171 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79755601 |
| 172 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78796807 |
| 173 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78506738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.79240267 |
| 2 | MP0003880_abnormal_central_pattern | 4.65003706 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.95786358 |
| 4 | MP0009046_muscle_twitch | 3.87624779 |
| 5 | MP0004270_analgesia | 3.40410100 |
| 6 | MP0002064_seizures | 3.26409746 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.25937827 |
| 8 | MP0009745_abnormal_behavioral_response | 3.13267906 |
| 9 | MP0003763_abnormal_thymus_physiology | 3.05429658 |
| 10 | MP0003436_decreased_susceptibility_to | 3.05306898 |
| 11 | MP0002272_abnormal_nervous_system | 3.00980695 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.96217138 |
| 13 | MP0005671_abnormal_response_to | 2.83287446 |
| 14 | MP0001486_abnormal_startle_reflex | 2.82923358 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.79519085 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.78439301 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.77571627 |
| 18 | MP0008569_lethality_at_weaning | 2.73876899 |
| 19 | MP0003303_peritoneal_inflammation | 2.64810850 |
| 20 | MP0001800_abnormal_humoral_immune | 2.64287315 |
| 21 | MP0002736_abnormal_nociception_after | 2.60052298 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.59824966 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.55197756 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 2.41260702 |
| 25 | MP0004858_abnormal_nervous_system | 2.40612313 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.39905250 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.38463920 |
| 28 | * MP0002067_abnormal_sensory_capabilities | 2.31131508 |
| 29 | MP0005387_immune_system_phenotype | 2.30838529 |
| 30 | MP0001790_abnormal_immune_system | 2.30838529 |
| 31 | MP0004142_abnormal_muscle_tone | 2.28408770 |
| 32 | MP0001970_abnormal_pain_threshold | 2.27921189 |
| 33 | MP0000685_abnormal_immune_system | 2.17660617 |
| 34 | MP0002420_abnormal_adaptive_immunity | 2.14065620 |
| 35 | MP0002723_abnormal_immune_serum | 2.12748094 |
| 36 | MP0003724_increased_susceptibility_to | 2.11585225 |
| 37 | MP0001819_abnormal_immune_cell | 2.09064510 |
| 38 | MP0002909_abnormal_adrenal_gland | 2.06991727 |
| 39 | MP0005025_abnormal_response_to | 2.01607881 |
| 40 | MP0001440_abnormal_grooming_behavior | 1.98728099 |
| 41 | MP0002419_abnormal_innate_immunity | 1.95862257 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.95380563 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.95010105 |
| 44 | MP0000955_abnormal_spinal_cord | 1.94132269 |
| 45 | MP0002184_abnormal_innervation | 1.88368542 |
| 46 | MP0003329_amyloid_beta_deposits | 1.85863330 |
| 47 | MP0002398_abnormal_bone_marrow | 1.85198178 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.85160101 |
| 49 | MP0003787_abnormal_imprinting | 1.80910795 |
| 50 | MP0004885_abnormal_endolymph | 1.74342630 |
| 51 | MP0003633_abnormal_nervous_system | 1.71344428 |
| 52 | MP0004947_skin_inflammation | 1.68943181 |
| 53 | MP0008260_abnormal_autophagy | 1.68436068 |
| 54 | MP0000716_abnormal_immune_system | 1.67732640 |
| 55 | MP0009785_altered_susceptibility_to | 1.62431161 |
| 56 | MP0004924_abnormal_behavior | 1.61506674 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.61506674 |
| 58 | MP0002822_catalepsy | 1.56023825 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.55186279 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.52059768 |
| 61 | MP0000920_abnormal_myelination | 1.51508906 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.50656381 |
| 63 | MP0003866_abnormal_defecation | 1.49765112 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.48872346 |
| 65 | * MP0002066_abnormal_motor_capabilities/c | 1.45563988 |
| 66 | MP0003690_abnormal_glial_cell | 1.44239505 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.42194657 |
| 68 | MP0005310_abnormal_salivary_gland | 1.40287834 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.38559686 |
| 70 | MP0002722_abnormal_immune_system | 1.38225626 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.38101229 |
| 72 | MP0002229_neurodegeneration | 1.37637097 |
| 73 | MP0003631_nervous_system_phenotype | 1.35846064 |
| 74 | MP0002405_respiratory_system_inflammati | 1.34396846 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.33593720 |
| 76 | MP0006082_CNS_inflammation | 1.29009990 |
| 77 | MP0003879_abnormal_hair_cell | 1.27961487 |
| 78 | MP0000778_abnormal_nervous_system | 1.26272477 |
| 79 | MP0000569_abnormal_digit_pigmentation | 1.25770792 |
| 80 | MP0002429_abnormal_blood_cell | 1.25520702 |
| 81 | MP0008961_abnormal_basal_metabolism | 1.23669231 |
| 82 | MP0001984_abnormal_olfaction | 1.21812254 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.21797167 |
| 84 | MP0001502_abnormal_circadian_rhythm | 1.21663000 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.20685662 |
| 86 | MP0010155_abnormal_intestine_physiology | 1.17838515 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 1.17718174 |
| 88 | MP0002148_abnormal_hypersensitivity_rea | 1.16096835 |
| 89 | MP0003122_maternal_imprinting | 1.15764979 |
| 90 | MP0009278_abnormal_bone_marrow | 1.14400374 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.13736864 |
| 92 | MP0003634_abnormal_glial_cell | 1.10520153 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 1.10179593 |
| 94 | MP0001845_abnormal_inflammatory_respons | 1.10148554 |
| 95 | MP0008872_abnormal_physiological_respon | 1.08407984 |
| 96 | MP0005166_decreased_susceptibility_to | 1.08374391 |
| 97 | MP0004130_abnormal_muscle_cell | 1.06091836 |
| 98 | MP0001533_abnormal_skeleton_physiology | 1.05287867 |
| 99 | MP0000751_myopathy | 1.04470589 |
| 100 | MP0004147_increased_porphyrin_level | 0.96782366 |
| 101 | MP0008874_decreased_physiological_sensi | 0.96647320 |
| 102 | MP0004742_abnormal_vestibular_system | 0.96426261 |
| 103 | MP0003632_abnormal_nervous_system | 0.95882054 |
| 104 | MP0001851_eye_inflammation | 0.94239555 |
| 105 | MP0003191_abnormal_cellular_cholesterol | 0.91727258 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.90977506 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.90109276 |
| 108 | MP0004381_abnormal_hair_follicle | 0.88544930 |
| 109 | MP0000604_amyloidosis | 0.87365924 |
| 110 | MP0002006_tumorigenesis | 0.86775309 |
| 111 | MP0002152_abnormal_brain_morphology | 0.86058979 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.85392655 |
| 113 | MP0001853_heart_inflammation | 0.85059290 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.84755523 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.84081439 |
| 116 | MP0005499_abnormal_olfactory_system | 0.83939012 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.83939012 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.83479478 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.83332401 |
| 120 | MP0002132_abnormal_respiratory_system | 0.82973917 |
| 121 | MP0001905_abnormal_dopamine_level | 0.80746415 |
| 122 | MP0005535_abnormal_body_temperature | 0.79973092 |
| 123 | MP0000858_altered_metastatic_potential | 0.78295741 |
| 124 | MP0003045_fibrosis | 0.77695935 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.77213280 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.75789060 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.73983188 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.73761757 |
| 129 | MP0002069_abnormal_eating/drinking_beha | 0.72817912 |
| 130 | MP0008469_abnormal_protein_level | 0.71841040 |
| 131 | MP0004484_altered_response_of | 0.71481697 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.70855708 |
| 133 | MP0003075_altered_response_to | 0.70275717 |
| 134 | MP0001873_stomach_inflammation | 0.70036864 |
| 135 | MP0004043_abnormal_pH_regulation | 0.69354094 |
| 136 | MP0001545_abnormal_hematopoietic_system | 0.68309850 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.68309850 |
| 138 | MP0000013_abnormal_adipose_tissue | 0.68106779 |
| 139 | MP0002933_joint_inflammation | 0.67991089 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.65862710 |
| 141 | MP0000747_muscle_weakness | 0.64255647 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.64219105 |
| 143 | MP0001177_atelectasis | 0.63877703 |
| 144 | MP0004085_abnormal_heartbeat | 0.63351073 |
| 145 | MP0004215_abnormal_myocardial_fiber | 0.60294951 |
| 146 | MP0003283_abnormal_digestive_organ | 0.59928901 |
| 147 | MP0004510_myositis | 0.59746518 |
| 148 | * MP0010769_abnormal_survival | 0.54672603 |
| 149 | MP0001943_abnormal_respiration | 0.53144988 |
| 150 | MP0001529_abnormal_vocalization | 0.51599924 |
| 151 | * MP0010768_mortality/aging | 0.50651013 |
| 152 | MP0003646_muscle_fatigue | 0.48840654 |
| 153 | * MP0003956_abnormal_body_size | 0.48226620 |
| 154 | * MP0010770_preweaning_lethality | 0.48134142 |
| 155 | * MP0002082_postnatal_lethality | 0.48134142 |
| 156 | MP0002638_abnormal_pupillary_reflex | 0.47146412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.85436981 |
| 2 | Focal motor seizures (HP:0011153) | 6.81628771 |
| 3 | Febrile seizures (HP:0002373) | 5.51639355 |
| 4 | Action tremor (HP:0002345) | 5.45355532 |
| 5 | Focal seizures (HP:0007359) | 5.32238715 |
| 6 | Visual hallucinations (HP:0002367) | 5.05556987 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.93786006 |
| 8 | Atonic seizures (HP:0010819) | 4.89080770 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.38662946 |
| 10 | Ankle clonus (HP:0011448) | 3.96352958 |
| 11 | Absence seizures (HP:0002121) | 3.95572033 |
| 12 | Myositis (HP:0100614) | 3.95164183 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.91927621 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.81641470 |
| 15 | Ventricular fibrillation (HP:0001663) | 3.77796661 |
| 16 | Optic neuritis (HP:0100653) | 3.74877067 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.74877067 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 3.72554894 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.72455441 |
| 20 | Ulnar claw (HP:0001178) | 3.70818549 |
| 21 | Orchitis (HP:0100796) | 3.66685885 |
| 22 | Meningitis (HP:0001287) | 3.66623749 |
| 23 | Postural instability (HP:0002172) | 3.64964859 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.59844864 |
| 25 | Dialeptic seizures (HP:0011146) | 3.59728631 |
| 26 | Truncal ataxia (HP:0002078) | 3.43760472 |
| 27 | Hemiplegia (HP:0002301) | 3.41627967 |
| 28 | Depression (HP:0000716) | 3.34618474 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.28130873 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 3.25812631 |
| 31 | Recurrent abscess formation (HP:0002722) | 3.21618836 |
| 32 | Scanning speech (HP:0002168) | 3.20678937 |
| 33 | Dysmetria (HP:0001310) | 3.20087459 |
| 34 | * Supranuclear gaze palsy (HP:0000605) | 3.17735063 |
| 35 | Dysdiadochokinesis (HP:0002075) | 3.17731261 |
| 36 | Encephalitis (HP:0002383) | 3.16267223 |
| 37 | Urinary urgency (HP:0000012) | 3.13877748 |
| 38 | Abnormal eating behavior (HP:0100738) | 3.12363856 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 3.10948739 |
| 40 | T lymphocytopenia (HP:0005403) | 3.10774249 |
| 41 | Obstructive sleep apnea (HP:0002870) | 3.07871963 |
| 42 | Intention tremor (HP:0002080) | 3.02141381 |
| 43 | Cellulitis (HP:0100658) | 3.02014096 |
| 44 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.00691449 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 3.00473932 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94279002 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94279002 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.93896793 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.92077655 |
| 50 | Peripheral hypomyelination (HP:0007182) | 2.90248714 |
| 51 | Insomnia (HP:0100785) | 2.88757416 |
| 52 | Pheochromocytoma (HP:0002666) | 2.85932070 |
| 53 | Vasculitis (HP:0002633) | 2.85668600 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.84227486 |
| 55 | Recurrent viral infections (HP:0004429) | 2.84222356 |
| 56 | Increased IgE level (HP:0003212) | 2.83079917 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.81171798 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80464848 |
| 59 | Gastrointestinal stroma tumor (HP:0100723) | 2.79841807 |
| 60 | Spastic gait (HP:0002064) | 2.78125054 |
| 61 | Colitis (HP:0002583) | 2.76137266 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.71574997 |
| 63 | Mutism (HP:0002300) | 2.71437025 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.68591457 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.66611106 |
| 66 | Poor eye contact (HP:0000817) | 2.65714238 |
| 67 | Bundle branch block (HP:0011710) | 2.63577943 |
| 68 | Onion bulb formation (HP:0003383) | 2.63573579 |
| 69 | Impaired social interactions (HP:0000735) | 2.63464543 |
| 70 | Abnormal social behavior (HP:0012433) | 2.63464543 |
| 71 | Status epilepticus (HP:0002133) | 2.62924728 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.62053706 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.61582214 |
| 74 | Anxiety (HP:0000739) | 2.61422475 |
| 75 | Fatigue (HP:0012378) | 2.60357861 |
| 76 | Papilledema (HP:0001085) | 2.60031953 |
| 77 | Hemiparesis (HP:0001269) | 2.58872288 |
| 78 | Genetic anticipation (HP:0003743) | 2.55626461 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55522662 |
| 80 | Obstructive lung disease (HP:0006536) | 2.55522662 |
| 81 | Progressive inability to walk (HP:0002505) | 2.53180427 |
| 82 | Recurrent skin infections (HP:0001581) | 2.51573214 |
| 83 | Bradykinesia (HP:0002067) | 2.49330010 |
| 84 | Termporal pattern (HP:0011008) | 2.48428148 |
| 85 | Insidious onset (HP:0003587) | 2.48428148 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 2.46416235 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.45398553 |
| 88 | Abnormality of T cells (HP:0002843) | 2.44224855 |
| 89 | Annular pancreas (HP:0001734) | 2.44016079 |
| 90 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.43902994 |
| 91 | Hammertoe (HP:0001765) | 2.40644619 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.40085433 |
| 93 | Stomatitis (HP:0010280) | 2.39873445 |
| 94 | Broad-based gait (HP:0002136) | 2.39062696 |
| 95 | Granulocytopenia (HP:0001913) | 2.38183541 |
| 96 | Keratoconjunctivitis (HP:0001096) | 2.36841304 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36024783 |
| 98 | Recurrent bronchitis (HP:0002837) | 2.34165302 |
| 99 | Torticollis (HP:0000473) | 2.31081482 |
| 100 | Lymphopenia (HP:0001888) | 2.31044531 |
| 101 | Abnormality of binocular vision (HP:0011514) | 2.30529346 |
| 102 | Diplopia (HP:0000651) | 2.30529346 |
| 103 | Pulmonary infiltrates (HP:0002113) | 2.27806508 |
| 104 | Hyperacusis (HP:0010780) | 2.26571275 |
| 105 | Amblyopia (HP:0000646) | 2.26176142 |
| 106 | Lower limb muscle weakness (HP:0007340) | 2.25997130 |
| 107 | Dysmetric saccades (HP:0000641) | 2.25992758 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25026396 |
| 109 | Spinal canal stenosis (HP:0003416) | 2.23482645 |
| 110 | Pointed chin (HP:0000307) | 2.22888268 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 2.22427046 |
| 112 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21252317 |
| 113 | Papilloma (HP:0012740) | 2.20929821 |
| 114 | Verrucae (HP:0200043) | 2.20929821 |
| 115 | Cerebral hypomyelination (HP:0006808) | 2.20499947 |
| 116 | Tetraplegia (HP:0002445) | 2.19978998 |
| 117 | Failure to thrive in infancy (HP:0001531) | 2.19591805 |
| 118 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19171868 |
| 119 | Pulmonary embolism (HP:0002204) | 2.16954184 |
| 120 | Pustule (HP:0200039) | 2.15848656 |
| 121 | Postural tremor (HP:0002174) | 2.15136888 |
| 122 | Clonus (HP:0002169) | 2.15051152 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 2.14680593 |
| 124 | * Slow saccadic eye movements (HP:0000514) | 2.14259019 |
| 125 | Fetal akinesia sequence (HP:0001989) | 2.14227573 |
| 126 | Hemoptysis (HP:0002105) | 2.13631194 |
| 127 | Hypercortisolism (HP:0001578) | 2.12697821 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11684035 |
| 129 | Steppage gait (HP:0003376) | 2.09433731 |
| 130 | IgG deficiency (HP:0004315) | 2.08807812 |
| 131 | * Memory impairment (HP:0002354) | 2.05015855 |
| 132 | Foot dorsiflexor weakness (HP:0009027) | 2.04795012 |
| 133 | Abnormality of the corticospinal tract (HP:0002492) | 2.04712578 |
| 134 | Abnormal EKG (HP:0003115) | 2.03893477 |
| 135 | Decreased motor nerve conduction velocity (HP:0003431) | 2.03195669 |
| 136 | Chest pain (HP:0100749) | 2.03085574 |
| 137 | Elfin facies (HP:0004428) | 2.02628437 |
| 138 | Gingivitis (HP:0000230) | 2.01397183 |
| 139 | Impaired vibratory sensation (HP:0002495) | 2.00685441 |
| 140 | Leukocytosis (HP:0001974) | 2.00339764 |
| 141 | Rigidity (HP:0002063) | 1.99860810 |
| 142 | Eosinophilia (HP:0001880) | 1.98747970 |
| 143 | Hypoplasia of the thymus (HP:0000778) | 1.97041915 |
| 144 | Megalencephaly (HP:0001355) | 1.95444416 |
| 145 | IgM deficiency (HP:0002850) | 1.95057865 |
| 146 | Osteomyelitis (HP:0002754) | 1.94780179 |
| 147 | Severe combined immunodeficiency (HP:0004430) | 1.94745597 |
| 148 | Gait ataxia (HP:0002066) | 1.93178930 |
| 149 | Distal sensory impairment (HP:0002936) | 1.93129747 |
| 150 | Abnormality of the fingertips (HP:0001211) | 1.92377125 |
| 151 | Increased IgM level (HP:0003496) | 1.92281480 |
| 152 | Focal dystonia (HP:0004373) | 1.91784018 |
| 153 | Rapidly progressive (HP:0003678) | 1.91017754 |
| 154 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.90277007 |
| 155 | Stereotypic behavior (HP:0000733) | 1.89384859 |
| 156 | Myotonia (HP:0002486) | 1.85127050 |
| 157 | Overriding aorta (HP:0002623) | 1.84962866 |
| 158 | Macroorchidism (HP:0000053) | 1.84448400 |
| 159 | Neoplasm of the heart (HP:0100544) | 1.83784162 |
| 160 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83625428 |
| 161 | Abnormality of the foot musculature (HP:0001436) | 1.83591883 |
| 162 | Increased circulating renin level (HP:0000848) | 1.82124333 |
| 163 | Craniofacial dystonia (HP:0012179) | 1.81797262 |
| 164 | Menstrual irregularities (HP:0000858) | 1.81768910 |
| 165 | Bradycardia (HP:0001662) | 1.80634068 |
| 166 | Resting tremor (HP:0002322) | 1.80152524 |
| 167 | Psychosis (HP:0000709) | 1.79844954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.51488353 |
| 2 | MAP3K9 | 3.65843537 |
| 3 | MAP4K1 | 3.55007945 |
| 4 | MINK1 | 3.34898224 |
| 5 | MAP3K4 | 3.15854053 |
| 6 | WNK1 | 2.96148575 |
| 7 | LMTK2 | 2.89025553 |
| 8 | MAP2K7 | 2.60351348 |
| 9 | MAP3K12 | 2.55473684 |
| 10 | STK38 | 2.49745197 |
| 11 | MAP2K4 | 2.45297072 |
| 12 | PAK6 | 2.26043855 |
| 13 | CAMKK1 | 2.24344203 |
| 14 | ERN1 | 2.20996812 |
| 15 | NTRK1 | 1.92822464 |
| 16 | GRK5 | 1.83131462 |
| 17 | KSR2 | 1.78717258 |
| 18 | TYK2 | 1.78369507 |
| 19 | BLK | 1.76295716 |
| 20 | NTRK2 | 1.74511937 |
| 21 | PINK1 | 1.70870938 |
| 22 | RIPK4 | 1.63462495 |
| 23 | TNK2 | 1.60441603 |
| 24 | PHKG1 | 1.60125023 |
| 25 | PHKG2 | 1.60125023 |
| 26 | SYK | 1.56946167 |
| 27 | MARK1 | 1.56147497 |
| 28 | TXK | 1.55934876 |
| 29 | PRKD3 | 1.55009184 |
| 30 | MAP2K3 | 1.51180955 |
| 31 | CDK19 | 1.47984546 |
| 32 | EPHA4 | 1.47313445 |
| 33 | CAMKK2 | 1.47171834 |
| 34 | UHMK1 | 1.45015600 |
| 35 | MAP3K11 | 1.30718303 |
| 36 | LATS2 | 1.28814229 |
| 37 | MAPK12 | 1.28535025 |
| 38 | SGK494 | 1.27600929 |
| 39 | SGK223 | 1.27600929 |
| 40 | CDK5 | 1.27155171 |
| 41 | TRIB3 | 1.26908728 |
| 42 | JAK3 | 1.26590393 |
| 43 | DAPK2 | 1.25877698 |
| 44 | IRAK4 | 1.25466259 |
| 45 | ZAP70 | 1.24531304 |
| 46 | BTK | 1.23282645 |
| 47 | PRKCH | 1.21677445 |
| 48 | MARK3 | 1.19045203 |
| 49 | MAP3K14 | 1.18978382 |
| 50 | ITK | 1.17934194 |
| 51 | FES | 1.17671402 |
| 52 | RET | 1.16831852 |
| 53 | GRK6 | 1.15897530 |
| 54 | MAPK13 | 1.15151502 |
| 55 | BMPR2 | 1.14506580 |
| 56 | CDK12 | 1.13158753 |
| 57 | MAP3K13 | 1.13009684 |
| 58 | SGK3 | 1.11537232 |
| 59 | CSK | 1.10807967 |
| 60 | SIK2 | 1.10457414 |
| 61 | JAK2 | 1.09112000 |
| 62 | MAP3K2 | 1.08845734 |
| 63 | HCK | 1.05888520 |
| 64 | SGK2 | 1.05284402 |
| 65 | PRKCG | 1.03558103 |
| 66 | ALK | 1.01010148 |
| 67 | FGFR4 | 1.00399099 |
| 68 | CAMK1 | 0.96183597 |
| 69 | LIMK1 | 0.95660265 |
| 70 | TNIK | 0.94950726 |
| 71 | IKBKE | 0.92658663 |
| 72 | STK11 | 0.91136606 |
| 73 | CDC42BPA | 0.90974841 |
| 74 | LCK | 0.88450330 |
| 75 | CAMK1G | 0.87306449 |
| 76 | TAOK1 | 0.83109137 |
| 77 | STK10 | 0.82638387 |
| 78 | TYRO3 | 0.81108801 |
| 79 | MAP3K1 | 0.80374621 |
| 80 | RIPK1 | 0.77340152 |
| 81 | SCYL2 | 0.77216444 |
| 82 | LYN | 0.76428571 |
| 83 | EPHB1 | 0.75012143 |
| 84 | ARAF | 0.74660340 |
| 85 | PLK2 | 0.73788891 |
| 86 | MARK2 | 0.73783268 |
| 87 | PDK1 | 0.72642872 |
| 88 | MAPK11 | 0.72182066 |
| 89 | MAPK7 | 0.71378125 |
| 90 | CAMK2G | 0.71272317 |
| 91 | TAOK2 | 0.70823115 |
| 92 | SMG1 | 0.69600869 |
| 93 | FGFR3 | 0.68928827 |
| 94 | BRSK1 | 0.68160527 |
| 95 | TBK1 | 0.68002428 |
| 96 | PRKCQ | 0.67672215 |
| 97 | MAP3K7 | 0.67385845 |
| 98 | PRKG2 | 0.66461278 |
| 99 | NEK1 | 0.66304637 |
| 100 | MAP3K10 | 0.64348311 |
| 101 | MAPK10 | 0.63100965 |
| 102 | GRK7 | 0.61752548 |
| 103 | PDPK1 | 0.60836148 |
| 104 | CSF1R | 0.60076237 |
| 105 | IRAK2 | 0.59541232 |
| 106 | FGR | 0.59445221 |
| 107 | CAMK2A | 0.58187601 |
| 108 | CDK15 | 0.58027477 |
| 109 | CDK18 | 0.57736851 |
| 110 | CAMK4 | 0.56678303 |
| 111 | TESK2 | 0.55675627 |
| 112 | OXSR1 | 0.55122827 |
| 113 | PNCK | 0.54457751 |
| 114 | PAK3 | 0.54261600 |
| 115 | STK39 | 0.53579123 |
| 116 | CDK14 | 0.52678805 |
| 117 | NEK6 | 0.52098438 |
| 118 | PRPF4B | 0.52049147 |
| 119 | SGK1 | 0.51320051 |
| 120 | PTK2B | 0.50457175 |
| 121 | KSR1 | 0.49885869 |
| 122 | ROCK2 | 0.49742225 |
| 123 | CDK11A | 0.48807097 |
| 124 | RPS6KA3 | 0.48445720 |
| 125 | HIPK2 | 0.48116824 |
| 126 | PIM1 | 0.48017246 |
| 127 | MAP3K3 | 0.47735863 |
| 128 | RAF1 | 0.46840959 |
| 129 | DAPK1 | 0.46353773 |
| 130 | TAOK3 | 0.46070471 |
| 131 | CAMK2B | 0.45933530 |
| 132 | DYRK1A | 0.45728155 |
| 133 | WNK4 | 0.44013901 |
| 134 | MAPKAPK5 | 0.41878722 |
| 135 | JAK1 | 0.41770732 |
| 136 | MUSK | 0.41650028 |
| 137 | PRKD2 | 0.41491386 |
| 138 | CAMK2D | 0.39202498 |
| 139 | PRKD1 | 0.38789191 |
| 140 | FYN | 0.38548210 |
| 141 | SIK3 | 0.36822431 |
| 142 | RPS6KA2 | 0.35883266 |
| 143 | ROCK1 | 0.35443054 |
| 144 | FER | 0.35186392 |
| 145 | CSNK1G2 | 0.34821721 |
| 146 | MAPK8 | 0.32407285 |
| 147 | MAP2K6 | 0.32159639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.53330490 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.07743765 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.65381023 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62863037 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53674014 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42463846 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.29286244 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.24732481 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.19582139 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15199453 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.11793200 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.05584935 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.01286632 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.98875498 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95349994 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.94236316 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.94094841 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88381804 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85803303 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.83543178 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80503781 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.79638037 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72090975 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.69887934 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69332115 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68675622 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68607978 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61471478 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.57801084 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.56008992 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.45683129 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.44486454 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43355893 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42768135 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41012836 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40502180 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.40187321 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36009534 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.31774629 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.31754833 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30078497 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.23642827 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22171735 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20560161 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17921197 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16643378 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13544629 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12759627 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.12199657 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11711365 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10658856 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.09442102 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05398560 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02489723 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01184797 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00816256 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.99902318 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99883697 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97190651 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95440675 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94156298 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93394464 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91430681 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90621201 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90146646 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.89512722 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89053847 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89005205 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87562913 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86362270 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86185234 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.85072708 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84933923 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84001909 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83254671 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82770601 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80427782 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80301664 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.79940407 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78643151 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77772327 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77081717 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76506153 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.76060015 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75383681 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75089931 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75087426 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74763089 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74464121 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73086146 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.72383981 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71473410 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69498313 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69292756 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69207667 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.69156331 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.65684146 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64015887 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63245494 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62717271 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62679527 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62404726 |
| 103 | Axon guidance_Homo sapiens_hsa04360 | 0.62183830 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61017628 |
| 105 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60914386 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60376938 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.59025421 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58550637 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.58276507 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57603844 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55809990 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55355899 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54832646 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51695796 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51578816 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49712632 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49223144 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47807014 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46693910 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46626724 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45693403 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.45426626 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.44069158 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40529558 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40408639 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39815056 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39145630 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38559640 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38190308 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.36991173 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36862455 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35039194 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34816174 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34809896 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34136249 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33362913 |
| 137 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32745155 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.32218415 |

